CU6 12.9% $5.41 clarity pharmaceuticals ltd

Research/Valuation, page-422

  1. 1,976 Posts.
    lightbulb Created with Sketch. 332
    Hard to determine what is most accurate. Wilsons use a DCF based off projected revenue from the assets clarity have available.

    You can also determine your own projections based on what you believe revenue is for claritys assets. You can punch it into any NPV calculator you find online and then best bet is to discount it based on percentage of success to approval.

    peer comparisons are also a good gauge. Also using peak sales multiplier as a potential acquisition price.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.